NCT02095353 is a clinical trial in Central Nervous System Neoplasms, sponsored by University of Nebraska.

Who is sponsoring NCT02095353?

NCT02095353 is sponsored by University of Nebraska.

What condition does NCT02095353 study?

NCT02095353 studies Central Nervous System Neoplasms.

Is NCT02095353 still recruiting?

NCT02095353 is currently terminated. Last updated 23 August 2023.

Last reviewed 2023-08-23 · How we verify

NCT02095353

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

Terminated Last updated 23 August 2023

What this trial tests

trial in Central Nervous System Neoplasms in 6 participants. Terminated before completion.

Timeline

1 September 2014

Primary endpoint
7 March 2017

7 March 2017

Quick facts

Lead sponsor	University of Nebraska
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	6
Start date	1 September 2014
Primary completion	7 March 2017
Estimated completion	7 March 2017
Sites	1 location across United States

Conditions studied

Central Nervous System Neoplasms — all drugs for Central Nervous System Neoplasms →

Sponsor

University of Nebraska

Who can join

19 and older, any sex, with Central Nervous System Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02095353 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 23 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02095353.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing